In summary, our study demonstrates BMP-3B as a novel target gene for Runx2 in bone lineage and lung cancer cells and provides insight into mechanisms that regulate epigenetic silencing of tumor growth inhibitors in lung cancer cells (Figure 5). This evidence concerns the gene RUNX2 and neoplasm.